March 17, 2017
Daiichi Sankyo and the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) will collaborate in open innovation research in cancer immunology with funding from Mitsubishi UFJ Capital, the three partners said on March 16. To pursue the collaborative research,...read more